Jun 3, 2022, 08:32 by Bob Davis

ASAM joined a large coalition of public health, harm reduction, HIV, and hepatitis organizations in sending a letter urging Congress to appropriate $150 million in fiscal year 2023 towards the Centers for Disease Control and Prevention’s (CDC) Infectious Diseases and Opioid Epidemic Program.

May 18, 2022, 14:13 by Bob Davis

Inclusion of Provisions Reflected in the Medication Access and Training Expansion (MATE) Act (H.R. 2067) and the Mainstreaming Addiction Treatment (MAT) Act (H.R. 1384) will help expand and mainstream addiction medicine.

May 12, 2022, 14:59 by Bob Davis

On May 11th, the Louisiana Society of Addiction Medicine (LSAM) sent a letter to members of the House Committee on Health and Welfare in support of SB 268. This legislation would require opioid treatment programs (OTPs) to provide medication for opioid use disorder (MOUD) to pregnant women.

May 11, 2022, 17:00 by Bob Davis

On May 11th, ASAM and other stakeholders sent a letter to U.S. House Energy and Commerce Committee leadership praising Section 321 of the Restoring Hope for Mental Health and Well-Being Act of 2022

May 10, 2022, 12:00 by Bob Davis

On May 10th, ASAM sent a letter[KMC1] to leadership of the U.S. House Committee on Energy and Commerce on H.R. 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 (the “Act”), in advance of the Subcommittee on Health’s legislative mark-up session on May 11th.

May 10, 2022, 09:41 by Bob Davis

On May 9th, the Louisiana Society of Addiction Medicine (LSAM) sent a letter to members of the Senate Committee on Judiciary C expressing support for HB 212.

May 3, 2022, 12:54 by Bob Davis

ASAM advocates for the need for sufficient appropriations for education, training, and loan repayment opportunities to expand the nation’s addiction treatment workforce.

Apr 28, 2022, 15:30 by Bob Davis

COSAM cautions that allowing law enforcement unrestricted access to the PDMP could compromise privacy and decrease treatment involvement.

Apr 28, 2022, 10:00 by Bob Davis

On April 28th, the Food and Drug Administration issued proposed rules to prohibit menthol as a characterizing flavor in cigarettes and to prohibit all characterizing flavors in cigars, following through on its promise of one year ago.

Apr 26, 2022, 10:00 by Bob Davis

Amid the ongoing opioid public health emergency, questions abound over the best way to spend federal funds to improve patient outcomes in addiction care.

Apr 21, 2022, 21:40 by Bob Davis

Today, ASAM praised the Biden-Harris Administration for releasing its inaugural National Drug Control Strategy, a critical roadmap to help address America’s addiction and overdose crisis.

Apr 14, 2022, 13:30 by Bob Davis

On April 12th, the Colorado Society of Addiction Medicine (COSAM) sent a letter to members of the House Committee on the Judiciary opposing calls to reinstate felony penalties for possession of small amounts of controlled substances. Currently, the General Assembly is considering HB 22-1326, a sweeping piece of legislation to address the rise in fentanyl overdoses in Colorado.

Apr 13, 2022, 11:46 by Bob Davis

On April 8th, the Colorado Society of Addiction Medicine (COSAM) sent a letter to the sponsors of HB 22-1064, expressing support for their bipartisan and bicameral legislation to regulate synthetic nicotine. Specifically, this legislation would expand the statutory definition of tobacco products to include synthetic nicotine and prohibit the marketing and sale of all flavored nicotine products.

Apr 13, 2022, 08:58 by Bob Davis

On April 8th, the Pennsylvania Society of Addiction Medicine (PSAM) sent letters to key stakeholders within the Philadelphia Department of Behavioral Health urging for the tobacco-free policy to be reintroduced at the city’s behavioral health facilities. For three years, the Department of Behavioral Health upheld a tobacco-free policy at all contingent behavioral health facilities. However, this policy was reversed late last year.

Apr 7, 2022, 10:21 by Matthew Bryant

The organizations asked the Committee to support the legislation that phases out "parity opt-outs" among self-funded state and local health plans.

Apr 5, 2022, 10:24 by Matthew Bryant

The workshop was focused on identifying gaps in existing opioid prescriber education offers, as well as core competencies that should be included in educational content for opioid prescribers and other healthcare providers.

Mar 24, 2022, 12:07 by Bob Davis

On March 23, 2022, the DEA announced a new option for DEA-registered practitioners working in hospitals, clinics, or emergency rooms, and for DEA-registered hospitals/clinics that allow practitioners to operate under their registration number.

Mar 24, 2022, 10:31 by Bob Davis

On March 23rd, the Tennessee Society of Addiction Medicine (TNSAM) sent a letter urging Governor Bill Lee to sign SB 2572 into law.

Mar 23, 2022, 10:52 by Bob Davis

In light on the ongoing tragedies related to Russia’s unprovoked invasion of Ukraine, on March 22, 2022, ASAM and other stakeholders sent a letter, spearheaded by former Representative Patrick J. Kennedy, to the Secretary of State Antony J. Blinken, and the U.S. Agency for International Development Administrator, Samantha Power.

Mar 21, 2022, 08:56 by Bob Davis

As part of the National Alliance for Underage Drinking, ASAM sent a letter to Representative Roybal-Allard, Representative Joyce, and Representative DeLauro in support of reauthorization of the Sober Truth on Preventing (“STOP Act”).